bone marrow transplantation Articles
-
The 3rd AIDS patient is "cured"! Has mankind finally conquered AIDS?
At an academic conference on Feb 15, U.S. experts announced the world's first female AIDS "cure," making it the third case of HIV infection to be cured. After therapy and withdrawal of antiviral drugs, HIVs were not identified in the patient's body for more than 14 months, indicating that the virus was in complete remission, according to academics. The key to this patient's recovery was a blood ...
-
Protecting hematology patients in Polish regional hospitals - Case Study
Poland has 38 large regional hospitals responsible for hematology and oncology. Genano has delivered a total of over 150 air purifiers to these hospitals. Of the 16 regions in Poland, 13 are using Genano to protect immunocompromised patients. Challenge Polish regional hospitals have recognized the need for protecting patients from infections by providing ultra pure air in patient ...
-
Long Read Sequencing Helps HLA Typing
HLA, human leukocyte surface antigen, a series of tightly interlocking motifs on the short arm of human chromosome 6, is the central basis for the immune system to recognize and differentiate between allogeneic substances. It is highly polymorphic and corresponds to a complex acquired immune system. It is importantly associated with a variety of autoimmune diseases, tumors, and infectious ...
By CD Genomics
-
Unveiling The Manifold Potentials: Mesenchymal Stem Cells & Bone Marrow Mesenchymal Stem Cells
In the vibrant realm of cellular biology and regenerative medicine, mesenchymal stem cells (MSCs) hold unparalleled potential for therapeutic applications. Particularly noteworthy are bone marrow mesenchymal stem cells (BM-MSCs), a subtype of MSCs. Their unique properties make them indispensable resources for developing ground-breaking solutions for various medical conditions. Mesenchymal stem ...
-
A Reflection on Blood Cancer Awareness Month: Patient Spotlight
As September and Blood Cancer Awareness Month wrap up, we want to reflect on a memorable conversation with Karen Thomas, a woman who received clonoSEQ® testing, and her physician, Dr. Hazma Hashmi, a hematologist-oncologist from the Medical University of South Carolina. At Adaptive, we know our diagnostic tests provide key information that help physicians and patients make treatment ...
-
Science: Knockout of this epigenetic gene gives CAR-T cells the ability to continuously attack cancer cells
Simply put, CAR-T is to transform the patient's immune T cells in vitro by biotechnology, so that they recognize antigens on the surface of tumor cells, and then inject these cells back into the patient to achieve the therapeutic effect of recognizing and killing cancer cells. In 2017, CAR-T therapy was first approved by the FDA for the treatment of blood cancers such as leukemia and lymphoma. ...
-
Prevent hospital acquired infections during construction projects
The issue of hospital acquired infections is a serious problem. According to several sources, three to four million hospital-acquired infections occur annually, with up to 80,000 fatalities. The costs of these infections are estimated to be between $4 billion and $5 billion per year (Air-Treatment Systems for Controlling Hospital acquired Infections, HPAC Engineering, April 2, 2008).Healthcare ...
-
Seven technologies to watch in 2022
Our fifth annual round-up of the tools that look set to shake up science this year. From gene editing to protein-structure determination to quantum computing, here are seven technologies that are likely to have an impact on science in the year ahead. Fully finished genomes Roughly one-tenth of the human genome remained uncharted when genomics researchers Karen Miga at the University of ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you